Mathys and PETER BREHM, based in Switzerland and Germany, respectively, entered into a long-term strategic sales cooperation. In 2020, the two will collaborate to supplement their portfolios with each other’s products for global sales.
Mathys specializes in primary hip, knee and shoulder implants and ceramic components (as well as sports medicine products), while PETER BREHM’s core competence lies in revision devices.
Initially, PETER BREHM will incorporate Mathys’ ceramic heads for use with BREHM hip stems and cups. Mathys will replace its legacy revision stem with BREHM’s modular revision MRP-TITAN device, which has been marketed since 1993. MRP-TITAN can cover a wider range of indications and offer more intraoperative solution approaches than Mathys’ previous option.
The collaborative distribution is expected to commence at the end of 1Q20.
“Through this cooperation, we can decisively complement our product portfolios and our offerings on both sides. We will check whether there are possibilities for the exchange of other products as merchandise. Our customers thus benefit from the many years of experience and know-how of two innovative orthopedics companies,” said Dr. Benjamin Reinmann, CEO of the Mathys Group. Marc Michel, CEO of PETER BREHM, added, “Thanks to the closing of ranks between the two time-honored companies, our customers and their patients benefit from the best of two perfectly complementary worlds.”
Mathys and PETER BREHM, based in Switzerland and Germany, respectively, entered into a long-term strategic sales cooperation. In 2020, the two will collaborate to supplement their portfolios with each other's products for global sales.
Mathys specializes in primary hip, knee and shoulder implants and ceramic components (as well as...
Mathys and PETER BREHM, based in Switzerland and Germany, respectively, entered into a long-term strategic sales cooperation. In 2020, the two will collaborate to supplement their portfolios with each other’s products for global sales.
Mathys specializes in primary hip, knee and shoulder implants and ceramic components (as well as sports medicine products), while PETER BREHM’s core competence lies in revision devices.
Initially, PETER BREHM will incorporate Mathys’ ceramic heads for use with BREHM hip stems and cups. Mathys will replace its legacy revision stem with BREHM’s modular revision MRP-TITAN device, which has been marketed since 1993. MRP-TITAN can cover a wider range of indications and offer more intraoperative solution approaches than Mathys’ previous option.
The collaborative distribution is expected to commence at the end of 1Q20.
“Through this cooperation, we can decisively complement our product portfolios and our offerings on both sides. We will check whether there are possibilities for the exchange of other products as merchandise. Our customers thus benefit from the many years of experience and know-how of two innovative orthopedics companies,” said Dr. Benjamin Reinmann, CEO of the Mathys Group. Marc Michel, CEO of PETER BREHM, added, “Thanks to the closing of ranks between the two time-honored companies, our customers and their patients benefit from the best of two perfectly complementary worlds.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
